Summit Financial’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Summit Financial's AMGN Position: Q1 2026 in Review
Summit Financial increased its Amgen (AMGN) stake by 34% in Q1 2026, buying an estimated $1.89M and bringing the position to 20,731 shares worth $7.29M. The position accounts for 0.09% of the portfolio, ranked #223.
Summit Financial first reported a position in AMGN in Q2 2021 and has held it in 20 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Summit Financial held 20,731 shares of Amgen worth $7.29M as of Q1 2026.
- Summit Financial bought 5,313 Amgen shares in Q1 2026, an estimated $1.89M.
- Amgen made up 0.09% of Summit Financial's portfolio in Q1 2026, its #223 holding.
- Summit Financial first reported a position in Amgen in Q2 2021 and has held it in 20 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.